For the Inventor, By the Inventor

Enter assignee name

Vasogen Ireland Limited

USPTO Granted Patents = 30

Forward Citations = 309

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Anthony E Bolton (12 out of 17 patents)

Taras Worona (8 out of 8 patents)

Duncan Newman (6 out of 18 patents)

4. Arkady Mandel (6 out of 14 patents)

5. Simon Treadwell (5 out of 36 patents)

6. Carlton Chong (4 out of 5 patents)

7. Thomas Blair Porter (4 out of 5 patents)

8. Sonya Mongomery (4 out of 4 patents)

9. Jeff Dayman (4 out of 7 patents)

10. Allen Muirhead (4 out of 4 patents)

11. Paul Moore (4 out of 4 patents)

12. Murray Voakes (4 out of 4 patents)

13. Liung Sen Liao (4 out of 4 patents)

14. Duncan John Stewart (2 out of 10 patents)

15. Jeffrey George Dayman (2 out of 14 patents)

30 patents: Sort by Forward Citations

1. 7597906 - Apoptosis-mimicking synthetic entities and use thereof in medical treatment (2009-10-06),

2. 7361164 - Multi-outlet medical dispensing device (2008-04-22),

3. 7279156 - Apoptotic entities for use in treatment of endothelium dysfunction disorders (2007-10-09),

4. 7273586 - Apparatus and process for conditioning mammalian blood (2007-09-25),

5. 7255880 - Treatment of endothelin-related disorders (2007-08-14),

6. 7250137 - Apparatus and process for conditioning mammalian blood (2007-07-31),

7. 7223391 - Method for treating mammals with modified mammalian blood (2007-05-29),

8. 7153649 - Treatment of congestive heart failure (2006-12-26),

9. 7132285 - Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders (2006-11-07),

10. 7128873 - Apparatus and process for conditioning mammalian blood (2006-10-31),

11. 7125897 - Combined therapies for atherosclerosis treatment (2006-10-24),

12. 7122208 - Compositions containing apoptotic entities (2006-10-17),

13. 6986888 - Method for treating mammals with modified mammalian blood (2006-01-17),

14. 6953591 - Apoptosis-mimicking synthetic entities and use thereof in medical treatment (2005-10-11),

15. D508995 - Syringe adaptor (2005-08-30),

Vasogen Ireland Limited is a leading biotechnology company specializing in the development and commercialization of innovative therapeutics for cardiovascular and inflammatory diseases. Their primary focus is on the clinical development of Celacade, a ground-breaking treatment for chronic heart failure and other related conditions. With a strong commitment to research and development, Vasogen Ireland Limited strives to improve patient outcomes and provide effective, life-changing therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

30 Patents

#4 in

#87 in Ireland

#21,212 in the World

Vasogen Ireland Limited

Forward Citations = 309

40 inventors:

Anthony E Bolton (12 out of 17 patents)

Taras Worona (8 out of 8 patents)

Duncan Newman (6 out of 18 patents)

4. Arkady Mandel (6 out of 14 patents)

5. Simon Treadwell (5 out of 36 patents)

Please report any incorrect information to support@idiyas.com

Loading…